Trial Profile
A multicenter multinational phase 3 randomized study to evaluate the safety and efficacy of treating colorectal cancer patients with recurrent liver metastases using the Litx system plus chemotherapy as compared to chemotherapy only.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2017
Price :
$35
*
At a glance
- Drugs Talaporfin (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 08 Jul 2010 Planned end date changed from 1 Dec 2009 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 21 May 2010 New source identified and integrated (Clinical Trials Registry - India CTRI2009-091-000295).
- 13 Apr 2010 Additional trial location (India) identified as reported by ClinicalTrials.gov.